Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 long-term randomized double-blind placebo-controlled study of troriluzole in adults with spinocerebellar ataxia
CTR20192484Phase 3Completed
- Sponsor
- Biohaven Ltd.
- Start
- Dec 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of troriluzole in spinocerebellar ataxia (SCA), sponsored by Biohaven Ltd.. Started Dec 2020; status: completed.
02
Drugs
troriluzole
03
Conditions
spinocerebellar ataxia (SCA)
Beyond the preview
Go deeper on CTR20192484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192484.